Prenatal BACs-on-Beads™: a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis

Objective Molecular cytogenetic techniques on uncultured prenatal samples are the sole tests applied in some countries in cases with advanced maternal age (AMA) or increased risk after prenatal screening. Moreover, there is a trend to perform invasive prenatal diagnosis (PD) during the first trimest...

Full description

Saved in:
Bibliographic Details
Published inPrenatal diagnosis Vol. 31; no. 5; pp. 500 - 508
Main Authors Vialard, F., Simoni, G., Aboura, A., De Toffol, S., Molina Gomes, D., Marcato, L., Serero, S., Clement, P., Bouhanna, P., Rouleau, E., Grimi, B., Selva, J., Gaetani, E., Maggi, F., Joseph, A., Benzacken, B., Grati, F. R.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.05.2011
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Molecular cytogenetic techniques on uncultured prenatal samples are the sole tests applied in some countries in cases with advanced maternal age (AMA) or increased risk after prenatal screening. Moreover, there is a trend to perform invasive prenatal diagnosis (PD) during the first trimester before ultrasound manifestations, so new rapid and reliable assays are necessary to investigate microdeletions not detectable with the conventional karyotype. We report the validation study of the prenatal bacterial artificial chromosomes‐on‐Beads™ (BoBs™; CE‐IVD), a bead‐based multiplex assay detecting chromosomes 13, 18, 21, X/Y aneuploidies and nine microdeletion regions having an overall detection rate of 1/1700. Method We retrospectively studied 408 selected samples and prospectively tested 212 consecutive samples ascertained for conventional karyotyping. Results We did not find false‐positive results. Triploidies were not detected. Maternal cell contamination of male samples up to 90% was unmasked inspecting gonosome profiles. Mosaic conditions at 20 to 30% were revealed. Failures were due to low amount of DNA. Conclusion Prenatal BoBs™ is a robust technology for the investigation of fetuses with normal karyotype with or without sonographic abnormalities. Running in parallel with the karyotype analysis, it can be proposed instead of rapid FISH or QF‐PCR providing rapid results on common aneuploidies and additional information regarding the microdeletion syndromes. Copyright © 2011 John Wiley & Sons, Ltd.
Bibliography:istex:B0B0C7FE35C414850425B35860DACE8E05300EF3
Theresults of this manuscript were presented at the 15th International Conference on Prenatal Diagnosis and Therapy (Amsterdam, The Netherlands, 11-14 July 2010).
ark:/67375/WNG-2FMFGH6S-H
ArticleID:PD2727
Theresults of this manuscript were presented at the 15th International Conference on Prenatal Diagnosis and Therapy (Amsterdam, The Netherlands, 11–14 July 2010).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0197-3851
1097-0223
1097-0223
DOI:10.1002/pd.2727